Table 1.

The baseline characteristics of the samples

	Phlebotomy N = 27	OCs N = 30	P-value*
Age, (y)	24 (4.06)	24.2 (5.2)	0.878
BMI, (kg/m2)	27.1 (5.04)	25.4 (5.3)	0.323
WHR,	0.8 (0.06)	0.7 (0.08)	0.223
HB, (g/dl)	14.1 (1.1)	14.3 (1.3)	0.166
HCT	40.4 (2.1)	39.6 (2.3)	0.330
Ferritin, (ng/mL)	74.2 (54.06)	48.5 (30.9)	0.070
SBP, (mm Hg)	102.3 (9.0)	100.2 (18.9)	0.526
DBP, (mm Hg)	67.6 (6.4)	66.2 (7.8)	0.503
Hirsutism score,	16.8 (6)	14.3 (7)	0.063
Acne, yes (%)	13 (74)	17 (56.6)	0.189
FAI, median	5.2 (1.6–12.8)	4.4 (1.4–4.7)	0.051
Total Testosterone, (ng/mL)	0.52 (0.3)	0.40 (0.1)	0.095
Androstenedione, (ng/mL)	4.7 (1.9)	4.1 (1.8)	0.350
SHBG, (nmol/L)	35.5 (20.9)	46.6 (46.8)	0.059
HOMA-IR, median	3.5 (1.3–4.5)	3.1 (1.4–3.5)	0.595
Insulin, (μU/mL)	9.5 (6.8–20)	10.8 (7.6–14.9)	0.626
GTT, fasting, (mg/dL)	84.3 (6.6)	83.8 (6.7)	0.813
GTT, 2 h, (mg/dL)	101.9 (12.7)	90.2 (23.9)	0.940
Cholesterol, (mg/dL)	178.5 (37.9)	178.7 (33.3)	0.985
Triglycerides, (mg/dL)	115.5 (107.9)	114.2 (48)	0.957
HDL-C, (mg/dL)	45.5 (15.1)	47.5 (10.3)	0.611
LDL-C, (mg/dL)	95.5 (26)	97.1 (22.7)	0.831
AMH, (ng/mL)	8.1 (6)	8.7 (6)	0.471
PSA, (ng/mL)	0.005 (0.002–0.009)	0.004 (0.002–0.020)	0.688

*The statistical significance level was set at 0.05; Values are given as mean (standard deviation) or median (25–75%), as appropriate.

BMI Body Mass Index; WHR Waist to Hip Ratio; HB Hemoglobin; HCT Hematocrit; SBP Systolic blood pressure; DBP Diastolic blood pressure; FAI Free Androgen Index; SHBG Sex Hormone Androgen Index; HOMA-IR Homeostatic Model Assessment for Insulin Resistance; GTT Glucose tolerance test; HDL High Density Lipoprotein; LDL Low Density Lipoprotein; AMH Anti Mullerian Hormone; PSA Prostate Specific Antigen.; SHBG Sex hormone-binding globulin; OCs oral contraceptives containing cyproterone acetate